Literature DB >> 7748161

Phagocytosis.

E J Brown1.   

Abstract

Phagocytosis is the process of recognition and engulfment of microorganisms or tissue debris that accumulate during infection, inflammation or wound repair. This ingestion, which is performed most efficiently by migrating, bone marrow-derived cells called 'professional phagocytes', is essential for successful host defense. Ingestion results when an invading microorganism is recognized by specific receptors on the phagocyte surface and requires multiple, successive interactions between the phagocyte and the target. Each of these interactions results in a signal transduction event, which is confined to the membrane and cytoskeleton around the ligated receptor and which is required for successful phagocytosis. Many molecules found at sites of inflammation or infection stimulate phagocytosis, so that efficient ingestion is confined to the site of infection or inflammation, which in turn limits the proinflammatory and tissue-destructive processes that accompany phagocytosis. This review summarizes current understanding of this critical component of host defense and of its regulation.

Entities:  

Mesh:

Year:  1995        PMID: 7748161     DOI: 10.1002/bies.950170206

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  22 in total

1.  Alteration of cytoskeletal structure, integrin distribution, and migratory activity by phagocytic challenge in cells from an ocular tissue--the trabecular meshwork.

Authors:  L Zhou; Y Li; B Y Yue
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-03       Impact factor: 2.416

Review 2.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

3.  CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process.

Authors:  Mark I Melhorn; Abigail S Brodsky; Jessica Estanislau; Joseph A Khoory; Ben Illigens; Itaru Hamachi; Yasutaka Kurishita; Andrew D Fraser; Anne Nicholson-Weller; Elena Dolmatova; Heather S Duffy; Ionita C Ghiran
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

4.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

6.  Signal transduction during Legionella pneumophila entry into human monocytes.

Authors:  P Y Coxon; J T Summersgill; J A Ramirez; R D Miller
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.

Authors:  Birgit Kraus; Horst Wolff; Erich F Elstner; Jörg Heilmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

8.  The Pallbearer E3 ligase promotes actin remodeling via RAC in efferocytosis by degrading the ribosomal protein S6.

Authors:  Hui Xiao; Hui Wang; Elizabeth A Silva; James Thompson; Aurélien Guillou; John R Yates; Nicolas Buchon; Nathalie C Franc
Journal:  Dev Cell       Date:  2014-12-18       Impact factor: 12.270

9.  Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression.

Authors:  T Nagaoka; Y Kaburagi; Y Hamaguchi; M Hasegawa; K Takehara; D A Steeber; T F Tedder; S Sato
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

10.  beta1 and beta2 integrins activate different signalling pathways in monocytes.

Authors:  Merit Reyes-Reyes; Nancy Mora; Gerardo Gonzalez; Carlos Rosales
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.